Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Inovio Pharmaceuticals, Inc. 401(K) Plan is a benefit plan reported by Inovio Pharmaceuticals, Inc. under EIN 33-0969592 and plan number 001. The latest loaded filing year is 2023. The filing reports 377 participants and $37,333,693 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $37,333,693
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $37,333,693
- Net assets (BOY)
- $31,385,710
Income & contributions
- Employer contributions
- $1,358,996
- Participant contributions
- $2,844,717
- Total contributions
- $4,393,614
- Total income / additions
- $10,362,331
Expenses & distributions
- Benefits paid
- $4,337,944
- Administrative expenses
- $76,404
- Total expenses
- $4,414,348
- Net increase / (decrease)
- $5,947,983